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Sunday. March 4. 2018 
16:00 – 18:00 Conference Check-in 
17:45 – 18:00 Welcoming Remarks 
Barry Buckland and Eli Keshavarz-Moore, Conference 
Chairs  
Beth Junker, ECI Technical Liaison 
Plenary Lectures  
18:00 – 18:50 Manufacturing biopharmaceuticals in the age of acceleration 
Chris Love, Massachusetts Institute of Technology, USA 
18:50 – 19:40 Development of live bacterial therapeutics 
John Aunins, Seres Therapeutics, USA 
19:40 – 19:45 Concluding Remarks 
19:45 – 20:30 Reception 




 Technical Sessions will be held in the Ballroom South. 
 Poster Sessions will be held in the Ballroom North. 
 The ECI office will be in the Stiha Room. 
 Meals will be in La Terraza 
 Audio, still photo and video recording by any device (e.g., cameras, cell phones, laptops, PDAs, 
watches) is strictly prohibited during the technical sessions, unless the author and ECI have 
granted prior permission. 
 Speakers – Please have your presentation loaded onto the conference computer prior to the 
session start (preferably the day before). 
 Speakers – Please leave discussion time as previously directed by your session chair. 
 Please do not smoke at any conference functions. 
 Turn your mobile telephones to vibrate or off during technical sessions. 
 Please write your name on your program so that it can be returned to you if lost or misplaced. 
 After the conference, ECI will send an updated participant list to all participants. Please check 
your listing now and if it needs updating, you may correct it at any time by logging into your ECI 
account. 
 
Monday. March 5. 2018 
07:00 – 08:30 Breakfast 
08:30 – 11:25 Session I: Primary Metabolites  
Session Chairs: Arindam Bose (AbiologicsB, LLC, USA) 
Brigitte Gasser (BOKU, Austria) 
08:30 – 08:35 Session Introduction 
08:35 – 09:10 Metabolic engineering strategies for producing oleochemicals in bacteria 
Brian F. Pfleger, University of Wisconsin-Madison, USA 
09:10 – 09:45 Improving biochemical yields with MixoFerm 
Shawn W. Jones, White Dogs Labs, USA 
09:45 – 10:00 Cyanobacteria as photosynthetic factories: Synthetic biology methods in 
the development of next-generation production platforms 
Hariharan Dandapani, University of Turku, Finland 
10:00 – 10:30 Coffee break 
10:30 – 10:55 Systems metabolic engineering of Corynebacterium 
glutamicum and Bacillus methanolicus for production of new products 
from alternative carbon sources 
Volker F. Wendisch, Bielefeld University, Germany 
10:55 – 11:20 MOMENTUM: Microbial Optimization via Metabolic Network Minimization 
Zhixia Ye, Duke University, USA 
11:20 – 11:25 Concluding Remarks 
11:25 – 11:30 Introduction of Plenary Lecture – Barry Buckland 
11:30 – 12:20 Plenary Lecture 
New bio-based supply chains for plant-based 
medicines Christina Smolke, Antheia, USA 
12:20 – 12:25 Concluding Remarks 
12:30 – 14:30 Lunch 
14:30 – 16:25 Session II: Therapeutic Proteins (Part 1)  
 (Sponsored by Sartorius Stedim Biotech GmbH) 
Session Chairs: Karen Polizzi (Imperial College London, United Kingdom) 
Eli Keshavarz-Moore (UCL, United Kingdom) Michael 
Hohn (Merck, USA) 
14:30 – 14:35 Session Introduction 
14:35 – 15:10 Learning from the mammalian expression system to develop a high titer- 
half antibody process in E. coli 
Emily Dong, Genentech, USA 
15:10 – 15:35 Matching secretion capacity via translation control 
Neil Dixon, Manchester University, United Kingdom 
Monday. March 5. 2018 (continued) 
15:35 – 16:00 C1: How the C1 platform will change the production approach for 
therapeutic proteins 
Ronen Tchelet, Dyadic, USA 
16:00 – 16:20 Gram Level scFv expression platform of Pichia pastoris 
Jen-Wei Chang, Development Center for Biotechnology, Taiwan 
16:20 – 16:25 Concluding Remarks 
16:25 – 16:55 Coffee/Tea break 
16:55 – 17:00 Introduction of Plenary Lecture – Eli Keshavarz-Moore 
17:00 – 17:50 Plenary Lecture 
mRNA vaccines and therapeutics: On the progress from promise to reality 
Hari Pujar, Moderna, USA 
19:00 – 20:30 Dinner 
20:30 – 23:00 Poster Session I (with social hour and dessert) 
Session Chairs: Stefanie Frank (UCL, United Kingdom) 
Eli Keshavarz-Moore (UCL, United Kingdom) 
Tuesday, March 6, 2018 
07:00 – 08:30 Breakfast 
08:30 – 12:30 Session III: Secondary Metabolites  
Session Chairs: Beth Junker (Bioprocess Advantage, USA) 
Yi Tang (University of California, Los Angeles, USA) 
08:30 – 08:35 Session Introduction 
08:35 – 09:05 Natural products by synthetic biology and microbial engineering 
Ben Shen, The Scripps Research Institute, USA 
09:05 – 09:35 An integrated strain improvement and process development program for 
the production of UK-2A, the precursor of the fungicide InatreqTM active 
Mark Mikola, Dow AgroSciences LLC, USA 
09:35 – 10:05 Scale up of low producing, potent secondary metabolites 
Scott Doncaster, BioVectra Inc., Canada 
10:05 – 10:25 One-pot synthesis of amino-alcohol using a de novo transketolase: 
Transaminase pathway in Pichia pastoris strain GS115 
Marie-Jose Henriquez, UCL, United Kingdom 
10:25 – 10:55 Coffee/Tea break (Sponsored by Amgen) 
10:55 – 11:25 Microbial engineering of new streptomyces sp. from extreme environments 
for novel antibiotics and anticancer drugs 
Juan Asenjo, University of Chile, Chile 
11:25 – 11:55 Genome-guided methods for discovering new natural product from fungi 
Yi Tang, University of California, Los Angeles, USA 
11:55 – 12:25 An efficient commercial platform for microbial engineering of natural 
products 
Hsien-Chung Tseng, Manus Bio, USA 
12:25 – 12:30 Concluding Remarks 
12:30 – 14:00 Lunch 
14:00 – 14:05 Introduction of Plenary Lecture – Barry Buckland 
14:05 – 15:00 Plenary Lecture 
Engineered polyketide synthases for production of commodity and 
specialty chemicals 
Jay Keasling, University of California-Berkeley, USA 
15:00 – 15:30 Coffee/Tea break (Sponsored by Genentech) 
15:30 – 17:35 Session IV: Biomaterials and Biofuels  
Session Chairs: Behnam Taidi (CentraleSupélec, LGPM, France) 
Joel Cherry (Amyris Inc., USA) 
15:30 – 15:35 Session Introduction 
Tuesday, March 6, 2018 (continued) 
15:35 – 16:05 Integrated bioengineering: Genomatica’s approach to rapid 
commercialization 
Michael Japs, Genomatica, USA 
16:05 – 16:45 Automating bioengineering: First the hands, then the head 
Ben Kaufmann-Malaga, Amyris, USA 
16:45 – 17:15 The circular bioeconomy and the concept of biorefinery 
Behnam Taidi, CentraleSupélec, LGPM, France 
17:15 – 17:30 Exploiting fatty acid metabolic pathway for production of short chain fatty 
acids in E. coli 
Kamran Jawed, ICGEB/Rensselaer Polytechnic Institute, USA 
17:30 – 17:35 Concluding Remarks 
17:35 – 20:30 “Dine Around” (free time for participants to experience Santa Fe dining) 
20:30 – 23:00 Poster Session II  
Session Chairs: Stefanie Frank (UCL, United Kingdom) 
Eli Keshavarz-Moore (UCL, United Kingdom) 
Wednesday, March 7, 2018 
07:00 – 08:30 Breakfast 
08:30 – 10:30 Session V: Therapeutics Proteins (Part II)  
Session Chairs: Karen Polizzi (Imperial College London, United Kingdom) 
Eli Keshavarz-Moore (UCL, United Kingdom)  
Michael Hohn (Merck, USA) 
08:30 – 08:35 Session Introduction 
08:35 – 09:10 Antibody production in micro-organisms 
Hanxiao Jiang, Amyris Inc., USA 
09:10 – 09:40 Process optimization, manufacturing changes from early to late phase 
development, and comparability of Resolaris 
Ying Buechler, aTyr Pharma, USA 
09:40 – 10:10 Promoter and process engineering for recombinant protein production in 
Pichia pastoris towards simple, fast and methanol-free cultivation regimes 
and high product titers 
Roland Prielhofer, ACIB, Austria 
10:10 – 10:25 Towards extracellular release of recombinant proteins from E.coli using 
antisense technology 
Shahin Heshmatifar, UCL, United Kingdom 
10:25 – 10:30 Concluding Remarks 
10:30 – 11:00 Coffee/Tea break (Sponsored by Biological E Limited) 
11:00 – 12:30 Session VI: Vaccines  
(Sponsored by Pfizer) 
Session Chairs: Barry Buckland (BiologicB, LLC, United Kingdom) 
Tiffany Rau (BioProcess Technology Consultants (BPTC), USA) 
11:00 – 11:05 Session Introduction 
11:05 – 11:40 Rational design of expression vectors for high quality biologics 
Kerry Love, Massachusetts Institute of Technology, USA 
11:40 – 12:00 High yield plasmid DNA production under oxygen limitation using 
microaerobically induced replication 
Alvaro Lara, Universidad Autónoma Metropolitana-Cuajimalpa, Mexico 
12:00 – 12:30 A Pseudomonas fluorescens- based platform for robust vaccine 
manufacturing 
Russell Coleman, Pfenex Inc, USA 
12:30 – 14:00 Lunch 
14:00 – 14:05 Introduction 
14:05 – 14:30 Enhancing the yield and quality of supercoiled plasmid through Plasmid 
Engineering 
Olusegun Folarin, UCL, UK
Wednesday. March 7. 2018 (continued) 
14:30 – 15:00 Computational fluid dynamics modeling for fermentation risk reduction 
during technology transfer and risk understanding 
Tracie Spangler, Merck & Co., Inc., USA 
15:00 – 15:30 Engineering of probiotic E.coli to treat metabolic disorders 
Paul Miller, Synlogic, USA 
15:30 – 15:35 Concluding Remarks 
15:35 – 16:00 Coffee/Tea break 
16:00 – 18:15 Conference Workshop 
Chair: Eli Keshavarz-Moore (UCL, United Kingdom) 
Topic: Leap-frogging microbial fermentation applications-what is 
needed, who can develop it, and how will it move the dial? 
16:00 – 16:05 Introduction 
16:05 – 16:15 Historical Perspective: Barry Buckland (BiologicB, LLC) 
16:15 – 16:35 Present Day: Equipment - Vendors and CMOs 
Sartorius, GE 
16:35 – 16:45 Present Day: Cost models; Buy versus build 
Tiffany Rau, BioProcess Technology Consultants (BPTC), USA 
16:45 – 16:55 Present Day: Secondary metabolites and chemicals 
Joel Cherry, Amyris Inc., USA 
16:55 – 17:05 A vision for therapeutic proteins and vaccine protein antigens 
Chris Love, Massachusetts Institute of Technology, USA 
17:05 – 17:15 Impact on human health: The unmet medical need is often affordability 
Steve Hadley, Bill & Melinda Gates Foundation, USA 
17:15 - 17:30 Role of Academia/Government/Industry Partnership 
NIIMBL, UCL Biomanufacturing Hub 
Barry Buckland, Eli Keshavarz-Moore 
17:30 – 18:10 Open Discussion 
18:10 – 18:15 Concluding Remarks 
18:15 – 18:30 Short biobreak 
18:30 – 18:35 Introduction to Closing Lecture - Eli Keshavarz-Moore 
Wednesday, March 7, 2018 (continued) 
18:35 – 19:10 Closing Plenary Lecture  
Opening microbial cells expands their capabilities 
Jim Swartz, Stanford University, USA 
19:45 – 23:00 Reception, Banquet Dinner and Poster Prizes 
Thursday. March 8. 2018 
07.00 – 09.30 Breakfast and Departures 
Poster Presentations 
 
1.  Enlarging the synthetic biology toolbox for Pichia pastoris: Golden Gate cloning and 
CRISPR/Cas9 
Roland Prielhofer, ACIB - Austrian Centre of Industrial Biotechnology, BOKU/DBT, Austria 
 
2.  Engineering vacuolar sorting pathways for efficient secretion of recombinant 
proteins 
Brigitte Gasser, BOKU/DBT, Austrian Centre for Industrial Biotechnology (ACIB), Austria 
 
3.  Genome-scale reconstruction of Salinispora tropica metabolism; Microbial 
engineering and its applications in secondary metabolite production 
Barbara A. Andrews, Centre for Biotechnology and Bioengineering, University of Chile, 
Chile 
 
4.  Using screening and classical strain improvement techniques to get the best 
performance of lactic acid bacteria 
Gunnar Øregaard, Chr Hansen, Denmark 
 
5.  Combined engineering of disaccharide transport and phosphorolysis for enhanced 
ATP yield from sucrose fermentation in Saccharomyces cerevisiae 
Wesley Marques, Delft University of Technology, The Netherlands 
 
6.  Engineering of Escherichia coli protein expression process development 
Chih-Hsi Fan, Development Center for Biotechnology, Taiwan 
 
7.  Gram level scFv expression platform of Phichi pastoris 
Jen-Wei Chang, Development Center for Biotechnology / Institute of Biologics, Taiwan 
 
8.  Redox potential control in anaerobic Clostridium beijerinckii fermentation using 
single-use vessels 
Ying Yang, Eppendorf Inc., USA 
 
9.  Production, immobilization and synthesis of pharmacological derivatives of lipase B 
from Candida antarctica in Pichia pastoris 
Julia Robert, Federal University of Rio de Janeiro, Brazil 
 
10.  Improvement of retinoids production in recombinant E. coli using glyoxylic acid 
Ji-Bin Park, Gyeongsang National University, South Korea 
 
11.  Sequential whole cell conversion process for production of D-psicose and D-
mannitol from D-fructose 
Seong-Hee Jeong, Gyeongsang National University, South Korea 
 
12.  Optimization of isoprene production using a metabolically engineered Escherichia 
Coli 
Seon-Yeong Jo, Gyeongsang National University, South Korea 
 
13.  Production of α-Bisabolol from metabolically engineered Escherichia coli 
Ju-Eon Park, Gyeongsang National University, South Korea 
  
  
14.  Engineering of Corynebacterium glutamicum for the secretory production of 
recombinant proteins via Tat-dependent pathway 
Jae Woong Choi, KAIST, South Korea 
 
15.  Expression and downstream purification of insulin molecules in Pichia pastoris 
Aster J. Escalante, Keck Graduate Institute, USA 
 
16.  Replacing animal-based hydrolysates in biopharmaceutical processes with animal-
free and chemically defined alternatives to reduce regulatory concerns 
Floyd L. Inman III, Kerry, USA 
 
17.  Synthetic biocatalytic modules for enhanced transformation of biological waste 
products 
Peter L. Bergquist, Macquarie University, Australia 
 
18.  Identifying the best Pichia pastoris base strain using functional genomics 
Joseph R. Brady, Massachusetts Institute of Technology, USA 
 
19.  Case study: Raman implementation for process lifecycle management in 
fermentation based processes 
Roberto I. Ortiz, Merck & Co, USA 
 
20.  E. coli strain engineering to minimize host cell protein contamination of recombinant 
target protein 
James Samuelson, New England Biolabs, Inc., USA 
 
21.  Sustainable production of β-Xanthophylls in Saccharomyces Cerevisiae 
Vicente Cataldo, Pontificia Universidad Católica de Chile, Chile 
 
22.  Coenzyme Q production by metabolic engineered Escherichia coli strains 
Irene Martinez, Pontificia Universidad Católica de Valparaíso, Chile 
 
  
23.  Automation and miniaturization of a microbial fermentation platform for the 
production of antibody fragments 
Geoff Brown, UCB, United Kingdom 
 
24.  Genetically engineered probiotic E. coli Nissle to consume amino acids associated 
with orphan metabolic diseases 
Ning Li, Synlogic Inc., USA 
 
25.  Towards extracellular release of recombinant proteins from E.coli using antisense 
technology  
Shahin Heshmatifar, UCL, United Kingdom 
 
26.  Effect of the oxygen transfer rate on oxygen-limited production of plasmid DNA by 
Escherichia coli 
Alvaro R. Lara, Universidad Autónoma Metropolitana-Cuajimalpa, Mexico 
 
27.  Methodology to rapidly assess enzyme cascades in aid of metabolic engineering of 
host cells 
Maria Villegas-Torres, Icesi University and University College London, Colombia 
 
28.  Enhancing the productivity of supercoiled plasmid upstream bioprocessing through 
plasmid engineering 
Olusegun Folarin, University College London, United Kingdom 
 
29.  Developing bacterial microcompartments for the recombinant production of proteins 
Stefanie Frank, University College London, United Kingdom 
 
30.  From screening to process optimization: AMBR technology to speed up microbial 
fermentation processes 
Kevin McHugh, Sartorius Stedim Biotech, USA 
 
31.  Enumeration method and medium design for a mixed culture of saccharomyces 
cerevisiae and chlorella vulgaris 
Behnam Taidi, CentraleSupélec, LGPM, France 
 
 
  
